Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) Consolidated Net Income (2018 - 2024)

Select Medical Holdings (SEM) has disclosed Consolidated Net Income for 8 consecutive years, with $37.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Consolidated Net Income fell 54.23% to $37.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $214.5 million, a 3.76% decrease, with the full-year FY2025 number at $214.5 million, down 3.98% from a year prior.
  • Consolidated Net Income was $37.7 million for Q4 2025 at Select Medical Holdings, down from $44.2 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $196.2 million in Q2 2021 to a low of -$141.8 million in Q4 2022.
  • A 5-year average of $53.3 million and a median of $56.9 million in 2022 define the central range for Consolidated Net Income.
  • Peak YoY movement for Consolidated Net Income: plummeted 313.8% in 2022, then skyrocketed 568.35% in 2024.
  • Select Medical Holdings' Consolidated Net Income stood at $66.3 million in 2021, then tumbled by 313.8% to -$141.8 million in 2022, then skyrocketed by 153.88% to $76.4 million in 2023, then increased by 7.95% to $82.5 million in 2024, then plummeted by 54.23% to $37.7 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Consolidated Net Income are $37.7 million (Q4 2025), $44.2 million (Q3 2025), and $57.9 million (Q2 2025).